Antonio Cusi
Psychiatry · Jacksonville, NCNPI 1487643151
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $114,449 of the $147,189 with a category attached, or 77.8%. AbbVie accounts for 77.6% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2022 at $63,613 and has fallen 67.6% since, to $20,637 in 2023. Among psychiatry clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 660 payments — averaging $223.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$114K
- Avanir Pharmaceuticals, Inc.$11K
- Otsuka America Pharmaceutical, Inc.$9K
- Takeda Pharmaceuticals U.S.A., Inc.$5K
- Validus Pharmaceuticals LLC$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- plus $5K from 25 others
What the payments were for
- Speaking & faculty fees$114,44978%
- Travel & lodging$22,38215%
- Food & beverage$10,0577%
- Education$2990%
- Gifts$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 233 | $114,278 |
| Avanir Pharmaceuticals, Inc. | 30 | $10,784 |
| Otsuka America Pharmaceutical, Inc. | 48 | $9,092 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $4,843 |
| Validus Pharmaceuticals LLC | 22 | $1,835 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $1,245 |
| Teva Pharmaceuticals USA, Inc. | 38 | $652 |
| Lundbeck LLC | 34 | $528 |
| Neurocrine Biosciences, Inc. | 10 | $419 |
| Eisai Inc. | 16 | $358 |
| Johnson & Johnson | 18 | $344 |
| Alkermes, Inc. | 16 | $322 |
| Ironshore Pharmaceuticals Inc. | 15 | $316 |
| Vanda Pharmaceuticals Inc. | 20 | $255 |
| Adlon Therapeutics L.p. | 12 | $223 |
| UCB, Inc. | 11 | $198 |
| Tris Pharma Inc | 11 | $194 |
| Jazz Pharmaceuticals Inc. | 7 | $193 |
| Arbor Pharmaceuticals, Inc. | 11 | $175 |
| Bausch Health US, LLC | 8 | $133 |
| Supernus Pharmaceuticals, Inc. | 10 | $113 |
| Neos Therapeutics, LP | 6 | $107 |
| Sunovion Pharmaceuticals Inc. | 6 | $100 |
| Merck | 6 | $97 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $88 |
| Shire North American Group Inc | 6 | $85 |
| Indivior Inc. | 5 | $70 |
| Vertical Pharmaceuticals, LLC | 4 | $61 |
| Almatica Pharma LLC | 3 | $55 |
| Corium, LLC | 1 | $16 |
| Pernix Therapeutics Holdings, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$147,189 in reported general payments places this provider in the 95th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Jacksonville
- Ajay VeeragandhamJacksonville$21K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
- James BarkerHickory$2.1M
- Brian FarahWinston Salem$605K
- Krishna TalluriMorrisville$591K
- Ramesh GihwalaGastonia$545K
- Keshavpal ReddyGreensboro$480K
- Robert MilletRaleigh$476K
- Steven SzaboDurham$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.